Eltrombopag for post-transplant thrombocytopenia: results of phase II randomized double blind placebo controlled trial

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; The University of Texas MD Anderson Cancer Center, Houston, TX;

Blood. 2015;126((23)): Abstract No. 738.
Study details